Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Oct-24 4:44 PM View:  | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Oct-24 | Sale | 3,607 | $0.88 | $3,171.64 | (< 1%) 1.14M to 1.14M | |
| 05-Sep-24 4:24 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 04-Sep-24 | Sale | 7,050 | $0.72 | $5,088.69 | (2%) 398.1K to 391.05K | |
| 05-Sep-24 4:26 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Sep-24 | Sale | 3,667 | $0.72 | $2,646.84 | (< 1%) 1.14M to 1.14M | |
| 05-Sep-24 4:28 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 04-Sep-24 | Sale | 3,971 | $0.72 | $2,866.27 | (1%) 277.85K to 273.88K | |
| 05-Sep-24 4:13 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 04-Sep-24 | Sale | 5,356 | $0.72 | $3,865.96 | (1%) 409.41K to 404.05K | |
| 08-Aug-24 4:31 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Aug-24 | Sale | 3,608 | $0.93 | $3,355.08 | (< 1%) 1.15M to 1.14M | |
| 31-Jul-24 4:14 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 30-Jul-24 | Sale | 2,883 | $1.06 | $3,055.98 | (< 1%) 329.51K to 326.63K | |
| 09-Jul-24 4:15 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Jul-24 | Sale | 3,616 | $0.85 | $3,077.22 | (< 1%) 1.15M to 1.15M | |
| 07-Jun-24 7:18 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 07-Jun-24 | Sale | 231,548 | $0.95 | $220,133.00 | (100%) 231.55K to 0 | |
| 07-Jun-24 7:18 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Jun-24 | Sale | 118,452 | $0.98 | $116,415.00 | (34%) 350.0K to 231.55K | |
| 07-Jun-24 7:18 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Jun-24 | Sale | 468,044 | $0.96 | $448,480.00 | (57%) 818.04K to 350.0K | |
| 06-Jun-24 4:02 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Jun-24 | Sale | 3,592 | $0.99 | $3,556.08 | (< 1%) 1.15M to 1.15M | |
| 04-Jun-24 6:51 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Jun-24 | Sale | 341,040 | $0.95 | $324,704.00 | (29%) 1.16M to 818.04K | |
| 06-Jun-24 4:03 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 04-Jun-24 | Sale | 652 | $0.99 | $645.48 | (< 1%) 398.76K to 398.1K | |
| 04-Jun-24 6:51 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 03-Jun-24 | Sale | 360,744 | $1.00 | $360,997.00 | (24%) 1.52M to 1.16M | |
| 04-Jun-24 6:51 PM View: | Pakianathan Deepika Director | Karyopharm Therapeutics, Inc. (KPTI) | 31-May-24 | Sale | 204,394 | $0.95 | $194,992.00 | (12%) 1.72M to 1.52M | |
| 07-May-24 4:56 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-May-24 | Sale | 3,576 | $1.13 | $4,040.88 | (< 1%) 1.16M to 1.15M | |
| 23-Apr-24 4:02 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 22-Apr-24 | Sale | 6,789 | $1.17 | $7,943.13 | (2%) 349.72K to 342.93K | |
| 05-Apr-24 5:20 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Apr-24 | Sale | 3,563 | $1.29 | $4,596.27 | (< 1%) 1.16M to 1.16M | |
| 06-Mar-24 4:14 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 05-Mar-24 | Sale | 3,573 | $1.30 | $4,644.90 | (< 1%) 1.16M to 1.16M | |
| 04-Mar-24 7:36 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 19,374 | $1.20 | $23,248.80 | (2%) 1.18M to 1.16M | |
| 04-Mar-24 7:38 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 3,576 | $1.20 | $4,291.20 | (1%) 281.43K to 277.85K | |
| 04-Mar-24 7:41 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 5,969 | $1.20 | $7,162.80 | (2%) 355.69K to 349.72K | |
| 04-Mar-24 7:37 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 5,109 | $1.20 | $6,130.80 | (1%) 398.62K to 393.51K | |
| 04-Mar-24 7:39 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 6,162 | $1.20 | $7,394.40 | (2%) 404.92K to 398.76K | |
| 04-Mar-24 7:40 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 01-Mar-24 | Sale | 6,155 | $1.20 | $7,386.00 | (2%) 335.67K to 329.51K | |
| 04-Mar-24 7:41 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 15,667 | $1.17 | $18,330.40 | (4%) 371.36K to 355.69K | |
| 04-Mar-24 7:37 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 21,840 | $1.17 | $25,552.80 | (5%) 420.46K to 398.62K | |
| 04-Mar-24 7:39 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 27,687 | $1.17 | $32,393.80 | (6%) 432.61K to 404.92K | |
| 04-Mar-24 7:40 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 16,311 | $1.17 | $19,083.90 | (5%) 351.98K to 335.67K | |
| 04-Mar-24 7:36 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 80,470 | $1.17 | $94,149.90 | (6%) 1.26M to 1.18M | |
| 04-Mar-24 7:38 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 29-Feb-24 | Sale | 16,973 | $1.17 | $19,858.40 | (6%) 298.4K to 281.43K | |
| 29-Feb-24 5:35 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 188,205 | -- | -- | 77% 244.4K to 432.61K | |
| 29-Feb-24 5:34 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 442,800 | -- | -- | 54% 821.45K to 1.26M | |
| 29-Feb-24 5:35 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 147,000 | -- | -- | 97% 151.4K to 298.4K | |
| 29-Feb-24 5:36 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 198,959 | -- | -- | 115% 172.4K to 371.36K | |
| 29-Feb-24 5:35 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 198,959 | -- | -- | 90% 221.5K to 420.46K | |
| 29-Feb-24 5:35 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 28-Feb-24 | Grant | 188,205 | -- | -- | 115% 163.77K to 351.98K | |
| 29-Feb-24 5:35 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 27-Feb-24 | Sale | 2,545 | $1.32 | $3,369.07 | (1%) 246.94K to 244.4K | |
| 20-Feb-24 4:59 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 15-Feb-24 | Sale | 5,847 | $1.33 | $7,783.44 | (3%) 169.62K to 163.77K | |
| 08-Feb-24 4:34 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-24 | Sale | 4,012 | $1.59 | $6,365.04 | (< 1%) 825.47K to 821.45K | |
| 08-Feb-24 4:36 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 06-Feb-24 | Sale | 4,205 | $1.59 | $6,671.23 | (2%) 251.15K to 246.94K | |
| 25-Jan-24 6:53 PM View: | Mano Michael SVP, General Counsel&Secretary | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 9,167 | -- | -- | 6% 142.23K to 151.4K | |
| 25-Jan-24 7:16 PM View: | Rangwala Reshma EVP & Chief Medical Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 14,167 | -- | -- | 9% 158.23K to 172.4K | |
| 25-Jan-24 7:40 PM View: | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 14,167 | -- | -- | 7% 207.33K to 221.5K | |
| 25-Jan-24 7:14 PM View: | Poulton Stuart EVP, Chief Development Officer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 13,333 | -- | -- | 9% 156.29K to 169.62K | |
| 25-Jan-24 6:47 PM View: | Mason Michael EVP, CFO & Treasurer | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 13,333 | -- | -- | 6% 237.82K to 251.15K | |
| 25-Jan-24 6:43 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 24-Jan-24 | Grant | 42,000 | -- | -- | 5% 783.47K to 825.47K | |
| 08-Jan-24 9:00 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Jan-24 | Sale | 4,114 | $0.82 | $3,373.48 | (< 1%) 787.58K to 783.47K | |
| 05-Dec-23 5:03 PM View: | Paulson Richard A. President and CEO Director | Karyopharm Therapeutics, Inc. (KPTI) | 04-Dec-23 | Sale | 3,622 | $0.79 | $2,861.38 | (< 1%) 791.2K to 787.58K |
